Search
for
Sort by
Research 211–240 of 682
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Contraception and the dermatologist
- Dermatologie care behind bars
- Skin manifestations of chronic kidney disease
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Dermatologic Reactions to Targeted Therapy
- Niosomes as Carrier in Dermal Drug Delivery
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Non-hemorrhage-related adverse effects of rivaroxaban
- A study on dermatoses of pregnancy
- Nocebo effect in Dermatology
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Psychoactive drugs and skin
- Drug eruptions in dermatology
- AUSTRALIAN TRIAL OF TOPICAL MINOXIDIL AND PLACEBO IN EARLY MALE PATTERN BALDNESS
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Multiple minute digitate hyperkeratosis
- Focal and Generalized Alopecia
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Skin disorders associated with the COVID‐19 pandemic: A review
- A machine learning and network framework to discover new indications for small molecules
- Psychotropic Medications and the Skin
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Stress, Hair Growth Control, and the Neuro-Endocrine-Immune Connection